Cargando…
mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment
Shwachman–Diamond syndrome (SDS) is a rare inherited bone marrow failure syndrome, resulting in neutropenia and a risk of myeloid neoplasia. A mutation in a ribosome maturation factor accounts for almost all of the cases. Lymphoid involvement in SDS has not been well characterized. We recently repor...
Autores principales: | Vella, Antonio, D’Aversa, Elisabetta, Api, Martina, Breveglieri, Giulia, Allegri, Marisole, Giacomazzi, Alice, Marinelli Busilacchi, Elena, Fabrizzi, Benedetta, Cestari, Tiziana, Sorio, Claudio, Bedini, Gloria, D’Amico, Giovanna, Bronte, Vincenzo, Poloni, Antonella, Benedetti, Antonio, Bovo, Chiara, Corey, Seth J., Borgatti, Monica, Cipolli, Marco, Bezzerri, Valentino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139896/ https://www.ncbi.nlm.nih.gov/pubmed/32150944 http://dx.doi.org/10.3390/cancers12030597 |
Ejemplares similares
-
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes
por: Bezzerri, Valentino, et al.
Publicado: (2016) -
Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes
por: Bezzerri, Valentino, et al.
Publicado: (2020) -
Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome
por: Bezzerri, Valentino, et al.
Publicado: (2022) -
Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variants
por: Kawashima, Nozomu, et al.
Publicado: (2023) -
Counteracting the Common Shwachman–Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing
por: Peretto, Laura, et al.
Publicado: (2023)